Original language | English |
---|---|
Article number | 360 |
Journal | BMC Cancer |
Volume | 14 |
DOIs | |
Publication status | Published - 2014 |
Externally published | Yes |
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
Charlotte Levin Tykjær Jørgensen, Christina Bjerre, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte Lisbet Nielsen
Research output: Contribution to journal › Article › peer-review